EUVIMEDEUVIMED entdecken
Crossref

Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era

Shuhei Kida, Shigeo Fuji, Toshitaka Morishima, Kayo Nakata, Isao Miyashiro, Jun Ishikawa

Clinical Lymphoma Myeloma and Leukemia · 2026-06 · 26 (6) · e774-e779

DOI: 10.1016/j.clml.2026.03.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-06. Verfasst von Shuhei Kida und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Oncology, Osaka General Medical Center, Osaka, Japan; Department of Hematology, Osaka International Cancer Institute, Os…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Acute myeloid leukemia (AML) mainly affects elderly patients, and real-world outcomes are often inferior to those observed in clinical trials. More clinically detailed real-world data are needed to better understand AML care. METHODS: This retrospective study analyzed treatment patterns and outcomes in patients with AML using a population-based dataset linking the Osaka Cancer Registry with hospital administrative data. We included 621 patients diagnosed with AML between 2010 and 2015, before the approval of venetoclax for AML in Japan. Patients were stratified by age group and first-line therapy, and outcomes were compared accordingly. RESULTS: The 2-year overall survival rate was 33.4% in the entire cohort, with substantial variation by age. Survival decreased sharply with age, ranging from 69.9% in patients aged 18 to 39 to 7.7% in those aged ≥ 80. Intensive therapy (idarubicin or daunorubicin plus cytarabine) was predominantly used in younger patients, while older patients more frequently received low-intensity regimens or supportive care. Among those who underwent allogeneic hematopoietic cell transplantation (allo-HCT) following intensive therapy, 2-year survival reached 78.2% in the 18 to 39 group but declined in older groups. Nonrelapse mortality exceeded relapse mortality in some age groups. CONCLUSIONS: Our findings underscore age as a key prognostic factor in AML and highlight the importance of optimizing treatment strategies for older patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsHumansJapanFemaleAgedMiddle AgedRetrospective StudiesMaleAged, 80 and overAdultTreatment OutcomeAdolescentYoung AdultHematopoietic Stem Cell TransplantationSulfonamidesBridged Bicyclo Compounds, Heterocyclic

Stichwörter der Autor:innen

Cancer registryOverall survivalPopulation-based registryReal-world dataallo-HSCT

Substanzen

SulfonamidesvenetoclaxBridged Bicyclo Compounds, Heterocyclic

Autor:innen und Institutionen

  • Department of Hematology and Oncology, Osaka General Medical Center, Osaka, Japan; Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Hematology, Osaka International Cancer Institute, Osaka, Japan. Electronic address: fujishige1231@gmail.com.
  • Cancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
  • Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kida, S., Fuji, S., Morishima, T., Nakata, K., Miyashiro, I., & Ishikawa, J. (2026). Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era. Clinical Lymphoma Myeloma and Leukemia, 26(6), e774-e779. https://doi.org/10.1016/j.clml.2026.03.012

Vancouver

Kida S, Fuji S, Morishima T, Nakata K, Miyashiro I, Ishikawa J. Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era. Clinical Lymphoma Myeloma and Leukemia. 2026;26(6):e774-e779. doi:10.1016/j.clml.2026.03.012

BibTeX
@article{Kida2026,
  author = {Kida, Shuhei and Fuji, Shigeo and Morishima, Toshitaka and Nakata, Kayo and Miyashiro, Isao and Ishikawa, Jun},
  title = {Real-World Treatment Patterns and Outcomes of Patients With Acute Myeloid Leukemia in Japan in the Pre-venetoclax Era},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {6},
  pages = {e774--e779},
  doi = {10.1016/j.clml.2026.03.012}
}
Kostenlos starten →